Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTEG.L Regulatory News (TEG)

  • There is currently no data for TEG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Interests & Board Appointment

25 Jun 2012 16:59

RNS Number : 1049G
TEG Group (The) PLC
25 June 2012
 



 

25 June 2012

The TEG GROUP PLC (TEG/L)

("TEG" or "the Company")

 

Directors Interests & Board Appointment

 

The TEG Group Plc, the AIM-listed cutting edge green technology company, which develops and operates organic composting and energy plants, announces that 66,940,435 New Ordinary Shares have today been admitted to trading on AIM pursuant to the Open Offer.

 

The Company now has 184,379,795 Ordinary Shares of 1p each in issue.

 

Director's Interests

 

Michael Fishwick, Chief Executive, participated in the Open Offer and his interest in the Ordinary Shares of the Company is now as follows:

 

Shareholding prior to the Open Offer

% of issued share capital held prior to the Open Offer

Uptake under the Open Offer

Shareholding following Admission

% of issued share capital held following Admission

Michael Fishwick

128,857

0.11%

166,666

295,523

0.16%

 

 

Open Offer fees

 

Pursuant to the arrangements entered into for the Open Offer and as set out in the Circular, the Major Shareholders have agreed to subscribe for further shares in the Company at the Offer Price in respect of certain of their fees which they are due. The Company has therefore issued a further 3,215,519 new Ordinary Shares to the Major Shareholders.

 

Pursuant to the engagement letter with N+1 Brewin and as set out in the Circular, the Company has issued 833,333 new Ordinary Shares at the Offer Price to N+1 Brewin.

 

Application will therefore be made to the London Stock Exchange for admission of 4,048,853 new Ordinary Shares. It is expected that admission will become effective and that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 29 June 2012. Following admission the Company will have 188,428,648 Ordinary Shares in issue.

 

 

Board Appointment

 

Following the passing of the Resolutions and as announced on 22 June 2012, John Rory Hamilton Maw (aged 47), has been appointed to the Board as a non-executive Director as a nominee of Bridges Ventures LLP. Mr. Maw is a Partner and the current Chief Financial Officer of Bridges Ventures LLP.

 

Mr. Maw has 15 years' corporate finance experience with Schroders and Morgan Stanley, focusing mainly on the consumer products and private equity sectors. In addition to his responsibilities for compliance and financial control and reporting as CFO of Bridges Ventures, Mr. Maw is actively involved in certain of the portfolio companies. Mr. Maw has a MA in Economics from Trinity College, Cambridge. He is Vice-Chairman of Guy's & St Thomas' NHS Foundation Trust and is also a Trustee of the Guy's & St Thomas' Charity.

 

The following further details are given in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies in relation to Mr. Maw's appointment:

Current directorships/partnerships

Bridges Ventures LLP

Bagnall Court Limited

Cheriton Park Hotel Limited

GSTC Health Investments Limited

GSTC Health Innovations Limited

St Thomas' Hospital Nominees

Guy's Hospital Nominees

Guy's & St Thomas' Enterprises Limited

Previous directorships/partnerships for the past five years

Bridges Capital Limited

Bridges Community Ventures Nominees Limited

Bridges Community Ventures (General Partner) Limited

Bridges Community Development Fund II (General Partner) Limited

Bridges Community Ventures (Scotland) Limited

Bridges Community Development Fund II (Scotland) Limited

Bridges Social Entrepreneurs Fund (General Partner) Limited

Bridges Social Entrepreneurs Fund (Scotland) Limited

Bridges Sustainable Property Fund (General Partner) Limited

The Careplaces (General Partner) Limited

UK Healthcare Property Fund (Scotland) Limited

School Stickers Holdings Limited

School Stickers Limited

GBF 2003 First Limited Liability Partnership

Well Heeled Shoes Limited

Box Media Limited

There is no other information that requires to be included in accordance with Rule 17 and Schedule 2 (g) of the AIM Rules for Companies in relation to Mr. Maw's appointment.

This announcement should be read in conjunction with the full text of the Circular posted to Shareholders on 6 June 2012, copies of which are available on the Company's website at www.theteggroup.plc.uk . Capitalised terms in this announcement have the same meaning as given in the Circular.

 

Contact:

The TEG Group Plc

Tel: 01772 644980

Michael Fishwick, Chief Executive

www.theteggroup.plc.uk

Peckwater PR

Tel: 07879 458 364

Tarquin Edwards

tarquin.edwards@peckwaterpr.co.uk

N+1 Brewin (NOMAD and Broker)

Tel : 0845 213 1000

Andrew Craig / Ben Wright

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGURAQUPPGAA
Date   Source Headline
3rd Sep 20213:40 pmRNSHolding(s) in Company
7th Jul 20217:00 amRNSHalf-Year Trading Update
5th Jul 20218:17 amRNSHolding(s) in Company
28th Jun 20219:27 amRNSNotice of Half-Year Trading Update
22nd Jun 20214:38 pmRNSPrice Monitoring Extension
11th Jun 20214:24 pmRNSNotification of Transactions by PDMRs
5th May 20212:17 pmRNSResult of AGM
29th Apr 20217:00 amRNSAppointment of Non-Executive Director
27th Apr 202112:36 pmRNSHolding(s) in Company
21st Apr 20217:00 amRNSChair Succession Announcement
9th Apr 20217:00 amRNSAnnual Report and AGM Notice
8th Apr 20213:11 pmRNSDirector/PDMR Shareholding
8th Apr 20213:05 pmRNSHolding(s) in Company
8th Apr 20212:59 pmRNSHolding(s) in Company
6th Apr 20212:16 pmRNSHolding(s) in Company
31st Mar 202111:56 amRNSDirector/PDMR Shareholding
29th Mar 20217:00 amRNSFull-Year Results
25th Mar 20217:00 amRNSNick Basing to step away in September
5th Mar 202111:13 amRNSNotice of Full-Year Results
3rd Mar 20219:00 amRNSHolding(s) in Company
26th Feb 202110:31 amRNSHolding(s) in Company
9th Feb 20211:24 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSFull-Year Trading Update
8th Jan 20217:00 amRNSHolding(s) in Company
22nd Dec 20205:28 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSPerformance Share Plan Awards
30th Nov 20204:40 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
25th Nov 20201:11 pmRNSHolding(s) in Company
25th Nov 202011:03 amRNSDirector/PDMR Shareholding
25th Nov 202011:02 amRNSHolding(s) in Company
4th Nov 20207:00 amRNSHolding(s) in Company
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20208:31 amRNSHolding(s) in Company
23rd Sep 20207:00 amRNSHalf-Year Results 26 weeks ended 28 June 2020
22nd Sep 20201:46 pmRNSHolding(s) in Company
21st Sep 20204:41 pmRNSSecond Price Monitoring Extn
21st Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:07 pmRNSNotice of Half-Year Results
8th Sep 20207:00 amRNSAppointment of New CEO
14th Aug 202011:46 amRNSReopening of 35 Centres throughout England
5th Aug 20205:38 pmRNSHolding(s) in Company
23rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jul 20204:35 pmRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSReopening of all Centres throughout England
17th Jul 202012:20 pmRNSAppointment of Senior Independent Director
26th Jun 20207:00 amRNSDirectorate Change
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.